GROWTH HORMONE & IGF RESEARCH
Scope & Guideline
Transforming Understanding of Growth Factors
Introduction
Aims and Scopes
- Clinical Implications of Growth Hormone Disorders:
The journal focuses on the clinical aspects of growth hormone disorders, including acromegaly, growth hormone deficiency, and their management strategies. It aims to provide insights into treatment modalities and their effectiveness. - Metabolic and Physiological Effects of IGFs:
Research published in the journal explores the metabolic roles of insulin-like growth factors, including their impact on conditions like diabetes, obesity, and cardiovascular health, thus bridging endocrinology with metabolic diseases. - Molecular Mechanisms and Signaling Pathways:
The journal covers studies detailing the molecular mechanisms of GH and IGF actions, including receptor interactions, downstream signaling pathways, and genetic influences, contributing to the fundamental understanding of these growth factors. - Pediatric and Adult Growth Disorders:
A significant emphasis is placed on both pediatric and adult populations, examining growth disorders from childhood through adulthood, and addressing transitional care between these life stages. - Innovative Therapeutic Approaches:
The journal highlights innovative therapeutic approaches for managing growth-related conditions, including pharmacological advances, gene therapy, and novel treatment protocols.
Trending and Emerging
- Comorbidities Associated with Growth Hormone Disorders:
Recent papers increasingly focus on the comorbidities associated with growth hormone disorders, such as metabolic syndrome, cardiovascular diseases, and psychological impacts, emphasizing the multifaceted nature of these conditions. - Patient-Centric Approaches and Perspectives:
There is a growing trend towards understanding patient and caregiver perspectives in managing growth hormone deficiencies, highlighting the importance of quality of life and patient experience in treatment outcomes. - Innovations in GH and IGF Therapy:
Emerging themes include the exploration of novel therapeutic approaches, such as long-acting growth hormone formulations and gene therapies, reflecting advancements in treatment options and patient management strategies. - Impact of GH on Neurological Health:
Research is increasingly examining the role of growth hormone in neurological health, including its effects on cognitive function and recovery in conditions like traumatic brain injury, signaling a broader understanding of GH's systemic effects. - Integration of Technology in Diagnosis and Treatment:
The integration of digital technologies and data analytics in diagnosing and managing growth disorders is on the rise, illustrating the journal's adaptation to contemporary clinical practices.
Declining or Waning
- Historical Perspectives on GH and IGF:
There appears to be a waning interest in historical perspectives and older treatment methodologies for growth hormone disorders, as researchers focus more on contemporary practices and novel interventions. - Animal Models in GH Research:
Research utilizing animal models to study growth hormone effects has become less frequent, possibly due to an increased focus on human clinical trials and translational research that directly impacts patient care. - Basic Science of GH and IGF Interaction:
The basic science exploring the interactions of GH and IGF at a cellular level has decreased, with a shift towards applied research that emphasizes clinical outcomes and therapeutic applications.
Similar Journals
Cardiovascular Endocrinology & Metabolism
Advancing the Science of Heart and HormonesCardiovascular Endocrinology & Metabolism is a leading open-access journal dedicated to advancing our understanding of the interconnections between cardiovascular health and endocrine functions. Published by Lippincott Williams & Wilkins, this journal serves as a vital resource for researchers and clinicians alike, providing timely insights into the intricate relationships between metabolic disorders and cardiovascular diseases. With an impressive impact factor and categorized in Q2 for both Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism, it holds a significant position within its respective fields. The journal has been fully open access since its inception in 2012, ensuring that critical research is accessible to a global audience. By fostering innovation and collaboration, Cardiovascular Endocrinology & Metabolism aims to promote better health outcomes and stimulate novel research directions, making it an essential resource for professionals striving to bridge the gaps between these two critical domains.
Aging Male
Championing the voices of aging male populations.Aging Male is an esteemed peer-reviewed journal published by Taylor & Francis Ltd, dedicated to the multidisciplinary field of geriatrics and gerontology. With an impressive impact factor, this journal ranks in the top quartile (Q2) of its categories, solidifying its reputation as a leading source of research and insights for professionals and academics in the field. Since transitioning to Open Access in 2021, Aging Male has broadened its reach, facilitating the dissemination of relevant research findings that address the complexities of aging in male populations globally. The journal accepts a wide range of contributions, including original research, reviews, and clinical studies, with particular emphasis on the biological, psychological, and social aspects of male aging. Researchers, clinicians, and students alike will find this journal an invaluable resource for advancing knowledge and practice in the dynamic landscape of geriatric medicine.
Molecular Plant
Innovating agricultural practices with cutting-edge research.Molecular Plant, published by CELL PRESS, is a premier journal dedicated to advancing the field of molecular biology and plant science. With an impressive impact factor reflecting its rigorous peer-review process and the high quality of its published research, this journal has achieved a remarkable Q1 ranking in both Molecular Biology and Plant Science categories as of 2023. Its Scopus rankings place it within the top echelons of its field, holding 2nd place in Agricultural and Biological Sciences - Plant Science, showcasing its vital role in disseminating impactful research. The journal covers a broad range of topics, including but not limited to, plant genetics, molecular interactions, and biotechnological advances. Research published in Molecular Plant has the potential to significantly influence agricultural practices and biotechnological applications, making it an essential resource for researchers, professionals, and students eager to stay at the forefront of plant research. Access options for the journal are tailored to accommodate a wide audience, facilitating engagement with cutting-edge findings and breakthroughs. As the field of plant science continues to evolve, Molecular Plant remains integral to fostering innovation and collaboration within the scientific community.
Cancer & Metabolism
Illuminating Metabolic Pathways in Cancer ProgressionCancer & Metabolism is a distinguished open-access journal published by BMC, dedicated to advancing the understanding of the complex interactions between cancer biology and metabolic processes. Since its inception in 2013, it has provided a platform for researchers, clinicians, and students to disseminate groundbreaking research and innovative findings within the fields of oncology and metabolism. The journal, identified by its E-ISSN 2049-3002, is recognized for contributing valuable insights into metabolic alterations that influence cancer progression, treatment responses, and overall patient outcomes. With a firm commitment to open access, Cancer & Metabolism ensures that research is freely available to the global scientific community, fostering collaboration and accelerating discoveries that can lead to improved therapeutic strategies. As a vital resource in cancer research, this journal appeals to a broad audience, including researchers looking to share their latest findings, professionals seeking to stay informed on cutting-edge developments, and students eager to delve into the relationship between metabolism and cancer.
GROWTH FACTORS
Advancing understanding of biological intricacies.GROWTH FACTORS, published by Taylor & Francis Ltd, is a prestigious journal dedicated to advancing the field of cell biology, clinical biochemistry, and endocrinology. With an ISSN of 0897-7194 and an E-ISSN of 1029-2292, this journal has served as a vital platform for the dissemination of groundbreaking research since its inception in 1988. Although it operates without an Open Access model, GROWTH FACTORS focuses on providing high-quality, peer-reviewed articles that explore the intricate roles of growth factors in biological processes and their implications in health and disease. Holding a Q4 ranking in Cell Biology and Q3 rankings in Clinical Biochemistry and Endocrinology according to the 2023 category quartiles, the journal is well-regarded in its field and plays a crucial role in informing researchers, professionals, and students alike about the latest findings and innovations in these areas. The journal's commitment to fostering scientific dialogue ensures that it remains a key resource for those looking to enhance their understanding of growth factors and their applications in clinical settings.
Clinical Pediatric Endocrinology
Illuminating the path to better health for children with metabolic disorders.Clinical Pediatric Endocrinology is a prestigious journal dedicated to advancing the field of pediatric endocrinology, published by the Japanese Society of Pediatric Endocrinology. With a respectable ISSN 0918-5739 and E-ISSN 1347-7358, this journal serves as a critical platform for innovative research spanning various aspects of endocrine disorders in children, including diabetes and metabolic conditions. Although it does not currently offer open access, it remains highly relevant in its category, being ranked in Q4 and Q3 tiers across multiple specialties as of 2023. With a publication history that spans from 1992 to 2024, this journal has contributed significantly to the literature, as evidenced by its inclusion in prominent databases. It invites submissions from researchers and practitioners worldwide, aiming to facilitate knowledge sharing and improve clinical practices in pediatric endocrinology. For those dedicated to enhancing care outcomes in children with endocrine disorders, Clinical Pediatric Endocrinology provides essential insights and fosters a community of engaged professionals.
Hormones-International Journal of Endocrinology and Metabolism
Pioneering Insights into Diabetes and Metabolic DisordersHormones - International Journal of Endocrinology and Metabolism, published by Springer International Publishing AG, is a vital resource within the field of Endocrinology, Diabetes, and Metabolism. Since its inception in 2005, this journal has made significant contributions to the understanding of hormonal mechanisms and their implications across various medical disciplines. With a current impact factor that places it in the Q3 category for Endocrinology and the Q2 category for miscellaneous Medicine – as indicated by its Scopus rankings – it stands out as a reputable platform for cutting-edge research and clinical findings. Although it operates under a subscription model, the journal's comprehensive scope encompasses basic and applied scientific studies, making it essential reading for researchers, clinicians, and students alike. The journal is headquartered in Germany with a strong commitment to promoting scholarly communication and knowledge dissemination within its specialized fields through the year 2024 and beyond.
Journal of the Endocrine Society
Connecting researchers and practitioners in the realm of hormones.Journal of the Endocrine Society, published by the ENDOCRINE SOC, stands as a prominent platform for disseminating significant research and findings within the field of endocrinology, diabetes, and metabolism. Established as an Open Access journal since 2017, it aims to increase the visibility and accessibility of vital scholarly contributions, allowing researchers and professionals from various backgrounds to engage with the latest insights in this rapidly evolving discipline. With an impressive Q2 ranking in Endocrinology, Diabetes and Metabolism, the journal is recognized for its impact, ranking #100 out of 244 in Scopus, highlighting its role in advancing scientific knowledge and fostering innovation. The journal, based in the United States at 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036, continues to enrich the academic landscape by converging state-of-the-art research and clinical applications through its publication cycle from 2017 to 2024. Researchers, students, and healthcare professionals are encouraged to explore this essential resource to stay at the forefront of endocrinological advancements.
MOLECULAR THERAPY
Empowering breakthroughs in genetics and pharmacology.MOLECULAR THERAPY, published by CELL PRESS, is a distinguished journal in the field of molecular biology and therapy, renowned for its significant contributions to drug discovery, genetics, and pharmacology since its inception in 2000. This prestigious journal, which holds a commendable position in the Q1 category across multiple disciplines including Drug Discovery, Molecular Medicine, and Molecular Biology, facilitates cutting-edge research and innovative therapies that aim to improve patient outcomes. With an impressive Scopus ranking that places it among the top journals in its field—such as rank #6 in Drug Discovery and #8 in Pharmacology—MOLECULAR THERAPY is crucial for researchers, professionals, and students seeking to advance their understanding and application of molecular techniques. The journal welcomes high-quality submissions that explore the therapeutic potential of molecular mechanisms, fostering a collaborative spirit within the scientific community to push the boundaries of modern medicine.
CELL PROLIFERATION
Advancing the Frontiers of Cellular ResearchCELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.